The range of psychosocial stress factors/processes (eg, chronic stress, distress states,
coping, social adversity) were reviewed as they relate to immune variables in cancer along …

Background In recent decades, advances in transplantation medicine, and improved
posttransplant care have reduced morbidity and mortality from hematopoietic stem cell …

Importance Patients with acute myeloid leukemia (AML) receiving intensive chemotherapy
experience substantial decline in their quality of life (QOL) and mood during their …

Background: National guidelines recommend regular measurement of functional status
among patients with cancer, particularly those who are elderly or high-risk, but little is known …

Because medical illness is associated with increased inflammation and an increased risk for
treatment-resistant major depressive disorder, anti-cytokine therapy may represent a novel …

Patient-reported outcomes (PROs) are an important tool to assess the impact of a new
therapy on symptom burden and health-related quality of life (HRQoL). Chimeric antigen …

Opinion statement Patients with hematologic malignancies and their families are among the
most distressed of all those with cancer. Despite high palliative care-related needs, the …

Background Allogeneic hematopoietic cell transplantation (HCT) is a widely used treatment
for hematologic cancers, with survival rates ranging from 25% to 78%. Known risk factors for …

Purpose Given the complexities and risks of allogeneic HCT, patients and their family
caregivers may experience elevated psychological distress, including symptoms of anxiety …

Data on psychological distress and its association with clinical outcomes in patients with
chronic graft-versus-host-disease (GVHD) are lacking. We used data of patients with chronic …